Last reviewed · How we verify
A Randomized Clinical Trial to Evaluate the Effects of High Dose Statin and Niacin Therapy on Excised Plaque Biomarkers in Patients Undergoing Carotid Endarterectomy (CEA) (MCAT)
This study will examine the effect of statin and niacin therapy on carotid plaque biomarkers
Details
| Lead sponsor | Merck Sharp & Dohme LLC |
|---|---|
| Phase | Phase 2 |
| Status | COMPLETED |
| Enrolment | 100 |
| Start date | 2009-04 |
| Completion | 2010-10 |
Conditions
- Carotid Atherosclerosis
Interventions
- Atorvastatin/niacin extended-release
- Atorvastatin
- Simvastatin
- Simvastatin
Primary outcomes
- Composite Score of Plaque Inflammation/Stability Gene Expression as Assayed by Ribonucleic Acid (RNA) Taqman Analysis — At time of carotid endarterectomy (after 4 to 12 weeks of dosing)
Excised carotid plaques were evaluated for the gene expression of 60 biomarkers associated with inflammation ("Hot" biomarkers) \& 25 biomarkers associated with stability ("Cold" biomarkers). Each biomarker was assayed using a quantitative polymerase chain reaction method and results were reported as a Cycle Threshold, (Ct). A Composite Score was calculated by averaging the Ct for each of the 25 "cold" genes, and subtracting the average Ct for the 60 "hot" genes. A higher composite score was associated with greater inflammation and a lower score was associated with stability (non-inflamed). - Plaque Instability Protein Composite Score — At time of carotid endarterectomy (after 4 to 12 weeks of dosing)
Each excised plaque was analyzed using an assay of 20 proteins that reflect plaque composition and inflammation. Each protein was assigned scaled signs, with a lower (negative) sign associated with plaque stability and a higher (positive) sign associated with plaque inflammation/instability. The Composite Score was the average amounts of all the 20 proteins with their associated signs. A higher Composite Score is associated with more plaque instability. - Total Cholesterol and Free Cholesterol Measured by Enzymatic Chromogenic Assay — At time of carotid endarterectomy (after 4 to 12 weeks of dosing)
Cholesterol ester was to be calculated by the following formula: Cholesterol Ester = Total Cholesterol - Free Cholesterol.